These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7061369)

  • 21. Detecting vancomycin intermediate Staphylococcus aureus.
    Commun Dis Rep CDR Wkly; 1997 Nov; 7(47):417, 20. PubMed ID: 9401190
    [No Abstract]   [Full Text] [Related]  

  • 22. Glycopeptide resistance amongst Staphylococcus spp.
    van den Braak N; van Belkum A; te Witt R; Verbrugh HA; Endtz HP
    J Antimicrob Chemother; 1998 Nov; 42(5):673-5. PubMed ID: 9848458
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bacteriophage types and the pattern of antibiotic resistance of Staphylococcus aureus during the years 1984-1987].
    Nowakowska M; Ekiel A; Rogala-Zawada D; Kapp-Burzyńska Z
    Pol Tyg Lek; 1989 Aug 21-28; 44(34-35):784-6. PubMed ID: 2535008
    [No Abstract]   [Full Text] [Related]  

  • 24. Sch 29482, laboratory evaluation of a new penem antibiotic.
    Kayser FH; Kuhn I
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():181-8. PubMed ID: 7061368
    [No Abstract]   [Full Text] [Related]  

  • 25. From the Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
    JAMA; 1997 Sep; 278(11):891-2. PubMed ID: 9302229
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antibacterial sensitivity of Staphylococcus aureus isolated from clinical specimens].
    Ozsan M; Tan G; Ozenci H
    Mikrobiyol Bul; 1989 Jul; 23(3):246-50. PubMed ID: 2487465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro activity of sanfetrinem against isolates of Streptococcus pneumoniae and Staphylococcus aureus.
    Johnson AP; Warner M; Speller DC
    J Antimicrob Chemother; 1998 Nov; 42(5):643-6. PubMed ID: 9848449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility to manuka honey of Staphylococcus aureus with varying sensitivities to vancomycin.
    Jenkins R; Wootton M; Howe R; Cooper R
    Int J Antimicrob Agents; 2012 Jul; 40(1):88-9. PubMed ID: 22580029
    [No Abstract]   [Full Text] [Related]  

  • 29. Activity of antimicrobial peptides, alone or combined with conventional antibiotics, against Staphylococcus aureus isolated from the airways of cystic fibrosis patients.
    Garbacz K; Kamysz W; Piechowicz L
    Virulence; 2017 Jan; 8(1):94-100. PubMed ID: 27450039
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prevalence of Staphylococcus aureus carriers of mecA gene susceptible to cefoxitine: OS-MRSA].
    Aleixandre-Górriz I; Domínguez-Márquez MV; Martínez-Macías O; Colomina J; Guerrero A
    Rev Esp Quimioter; 2014 Sep; 27(3):215-6. PubMed ID: 25229377
    [No Abstract]   [Full Text] [Related]  

  • 31. Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit.
    Cepeda J; Hayman S; Whitehouse T; Kibbler CC; Livermore D; Singer M; Wilson AP
    J Antimicrob Chemother; 2003 Sep; 52(3):533-4. PubMed ID: 12888581
    [No Abstract]   [Full Text] [Related]  

  • 32. Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus.
    Gadepalli R; Dhawan B; Mohanty S; Kapil A; Das BK; Chaudhry R
    Indian J Med Res; 2006 Apr; 123(4):571-3. PubMed ID: 16783051
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy.
    Mariani PG; Sader HS; Jones RN
    J Antimicrob Chemother; 2006 Aug; 58(2):481-3. PubMed ID: 16847029
    [No Abstract]   [Full Text] [Related]  

  • 34. Heterogeneous vancomycin-resistant Staphylococcus aureus (hetero-VISA) in Singapore.
    Sng LH; Koh TH; Wang GC; Hsu LY; Kapi M; Hiramatsu K
    Int J Antimicrob Agents; 2005 Feb; 25(2):177-9. PubMed ID: 15664490
    [No Abstract]   [Full Text] [Related]  

  • 35. Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin.
    Price J; Atkinson S; Llewelyn M; Paul J
    Clin Infect Dis; 2009 Apr; 48(7):997-8. PubMed ID: 19260820
    [No Abstract]   [Full Text] [Related]  

  • 36. In-vitro activity of Sch 29482--a new penem antibiotic.
    Muench RL; Mayhew AL; Hindler JA; Hewitt WL; Young LS
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():71-8. PubMed ID: 7061378
    [No Abstract]   [Full Text] [Related]  

  • 37. 'Methicillin resistant' Staphylococcus aureus infections during 1978-79: clinical and bacteriologic observations.
    Giamarellou H; Papapetropoulou M; Daikos GK
    J Antimicrob Chemother; 1981 Jun; 7(6):649-55. PubMed ID: 6972943
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-streptococcal activity of Sch 29482--a novel penem antibiotic.
    Yu PK; Washington JA
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():195-8. PubMed ID: 7061370
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative in-vitro activity of Sch 29482, a new penem antibiotic.
    Reeves DS; Bywater MJ; Holt HA
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():31-40. PubMed ID: 7061375
    [No Abstract]   [Full Text] [Related]  

  • 40. Cefoxitin disk diffusion test--better predictor of methicillin resistance in Staphylococcus aureus.
    Gupta M; Singh NP; Kumar A; Kaur IR
    Indian J Med Microbiol; 2009; 27(4):379-80. PubMed ID: 19736419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.